Show simple item record

dc.contributor.authorHuang, G.D.
dc.contributor.authorAltemose, J.K.
dc.contributor.authorO'Leary, T.J.
dc.date.accessioned2019-07-15T16:12:07Z
dc.date.available2019-07-15T16:12:07Z
dc.date.issued2017
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85018522620&doi=10.1016%2fj.cct.2017.04.002&partnerID=40&md5=099ba52833d5a97c20c3ebc6b5cfaa01
dc.identifier.urihttp://hdl.handle.net/10713/9888
dc.description.abstractEfforts to make clinical trials and their results more publicly available have been increasing in recent years. However, there is a need to better understand ways to achieve these goals aimed at benefiting a diverse set of stakeholders. Since 2005, the U.S. Department of Veterans Affairs Office of Research and Development (ORD), part of the nation's largest integrated health care system, has required the clinical trials its funds to be registered in ClinicalTrials.gov as a condition of the award. Furthermore, summary results of studies active since 2007 have been included in the registry. This paper highlights ORD activities, challenges and lessons at investigator, study, and organizational levels. Key factors in ORD's approach include: a mission-oriented approach; leadership support; a working group for organizational policies and practices; prioritizing communication; and recognizing the needs of investigators. Making clinical trials available to the public should represent a focal point for groups desiring to maximize the contributions from such research. The ability to do so must involve a commitment by sponsors and a critical evaluation of the reasons, requirements and resources at multiple levels. Copyright 2017en_US
dc.description.sponsorshipThis work was funded by the VA Cooperative Studies Program (ID#0113) and VA Health Services Research and Development Service (HFP 99-112).en_US
dc.description.urihttps://www.doi.org/10.1016/j.cct.2017.04.002en_US
dc.language.isoen_USen_US
dc.publisherElsevier Inc.en_US
dc.relation.ispartofContemporary Clinical Trials
dc.subjectAccessen_US
dc.subjectClinical trialsen_US
dc.subjectClinicalTrials.goven_US
dc.subjectPolicyen_US
dc.subjectVeteransen_US
dc.titlePublic access to clinical trials: Lessons from an organizational implementation of policyen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.cct.2017.04.002
dc.identifier.pmid28414147


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record